The above results illustrate that nsP3-M358L interacts with PKR and suppresses its activation, thus endowing M1-NS3M with the ability to evade antiviral responses by inhibiting the activation of the PKR-STAT1-IFN signaling pathway and enhancing virus replication in tumor cells. The gene discussed is SH2D3C; the disease is neoplasm.